PD-0183812

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NamePD-0183812

Drug Alias NamePD-183812PD-0183812

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin-dependent kinase 4 inhibitors

TargetsCyclin-dependent kinase 4

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

ATC CodeN/A